SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 9, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

June 15, 2030

Conditions
AneurysmAneurysm, Ruptured
Interventions
DEVICE

SEAL Device

Using standard interventional endovascular techniques, the device is navigated via the push wire delivery system through compatible neurovascular microcatheters to the aneurysm lumen or target site. The device is positioned into its target aneurysm lumen and is electrically detached by the operator with a hand-held, battery-powered detachment handle designed specifically for the SEAL Embolization System.

Trial Locations (4)

1023

RECRUITING

Auckland City Hospital, Auckland

Unknown

RECRUITING

Angiosur, Itagüi

RECRUITING

Punjab Institute of Neuroscience (PINS), Lahore

08035

RECRUITING

Hospital Universitari Vall d'Hebron, Barcelona

Sponsors
All Listed Sponsors
lead

Galaxy Therapeutics INC

INDUSTRY